Cholestabyl en es it fr

Cholestabyl Brand names, Cholestabyl Analogs

Cholestabyl Brand Names Mixture

  • No information avaliable

Cholestabyl Chemical_Formula


Cholestabyl RX_link

No information avaliable

Cholestabyl fda sheet

Cholestabyl msds (material safety sheet)

Cholestabyl MSDS

Cholestabyl Synthesis Reference

No information avaliable

Cholestabyl Molecular Weight

560.684 g/mol

Cholestabyl Melting Point


Cholestabyl H2O Solubility

1.2 mg/mL (at 20°C, 1.2%)

Cholestabyl State


Cholestabyl LogP


Cholestabyl Dosage Forms

Powder (vials of 500 mg or 2 g sterile powder for preparing injections or for oral use)

Cholestabyl Indication

Used to treat acute iron or aluminum toxicity (an excess of aluminum in the body) in certain patients. Also used in certain patients with anemia who must receive many blood transfusions.

Cholestabyl Pharmacology

Deferoxamine, otherwise known as desferrioxamine or desferal, is a chelating agent used to remove excess iron or aluminum from the body. It acts by binding free iron or aluminum in the bloodstream and enhancing its elimination in the urine. By removing excess iron or aluminum, the agent reduces the damage done to various organs and tissues, such as the liver.

Cholestabyl Absorption

Deferoxamine is rapidly absorbed after intramuscular or subcutaneous administration, but only poorly absorbed from the gastrointestinal tract in the presence of intact mucosa.

Cholestabyl side effects and Toxicity

Intravenous LD50 in mouse, rat, and rabbit is 340 mg/kg, 520 mg/kg, and 600 mg/kg, respectively. Subcutaneous LD50 in mouse and rat is 1600 mg/kg and >1000 mg/kg, respectively. Oral LD50 in mouse and rat is >3000 mg/kg and >1000 mg/kg, respectively. Nephrotoxicity, ototoxicity and retinal toxicity have been reported following long-term administration for chronic iron overload.

Cholestabyl Patient Information

Cholestabyl Organisms Affected

Humans and other mammals